CIK 0001604821
- Large accelerated filer
Natera, Inc.
Sign in to watch- Ticker
- NTRA
- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 010894487
- Phone
- +1 650-249-9090
- Business address
- 13011 MCCALLEN PASS, BUILDING A SUITE 100, AUSTIN, TX, 78753
- Former names
- Natera, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $104,832,418
- in 28 filings, $104.8M under 10b5-1 plans
Net −$104,832,418. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Rabinowitz Matthew −$72.3M EXECUTIVE CHAIRMAN sold 9% of stake
- Sheena Jonathan −$13.8M Director sold 83% of stake
- Moshkevich Solomon −$9.5M PRESIDENT, CLINICALDIAGNOSTICS sold 21% of stake
- Chapman Steven Leonard −$5.0M CEO AND PRESIDENT sold 12% of stake
- Brophy Michael Burkes −$2.5M CHIEF FINANCIAL OFFICER sold 11% of stake
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-02-23 | Rabinowitz Matthew EXECUTIVE CHAIRMAN | Exercise or conversion | +380,036 | $2.66 | $1.0M | 1,050,036 |
| 2024-02-23 | Rabinowitz Matthew EXECUTIVE CHAIRMAN | Exercise or conversion · Stock Option (right to buy) | −380,036 | 0 | ||
| 2024-02-16 | ROSENMAN HERM Director | Exercise or conversion | +93,901 | $2.66 | $249K | 155,586 |
| 2024-02-16 | ROSENMAN HERM Director | Sale | −57,954 | $69.08 | $4.0M | 97,632 |
| 2024-02-16 | ROSENMAN HERM Director | Sale | −35,947 | $69.85 | $2.5M | 61,685 |
| 2024-02-16 | ROSENMAN HERM Director | Exercise or conversion · Stock Option (right to buy) | −93,901 | 0 | ||
| 2024-02-07 | Sheena Jonathan Director | Sale 10b5-1 | −500 | $70.10 | $35K | 17,655 |
| 2024-02-07 | Sheena Jonathan Director | Sale 10b5-1 | −500 | $70.10 | $35K | 17,655 |
| 2024-02-07 | Sheena Jonathan Director | Sale 10b5-1 | −5,000 | $70.10 | $350K | 473,585 |
| 2024-02-06 | Brophy Michael Burkes CHIEF FINANCIAL OFFICER | Exercise or conversion 10b5-1 | +10,070 | $9.29 | $94K | 80,716 |
| 2024-02-06 | Brophy Michael Burkes CHIEF FINANCIAL OFFICER | Exercise or conversion 10b5-1 | +23,959 | $19.68 | $472K | 104,675 |
| 2024-02-06 | Brophy Michael Burkes CHIEF FINANCIAL OFFICER | Sale 10b5-1 | −34,029 | $70.03 | $2.4M | 70,646 |
| 2024-02-06 | Brophy Michael Burkes CHIEF FINANCIAL OFFICER | Exercise or conversion · Stock Option (right to buy) 10b5-1 | −10,070 | 0 | ||
| 2024-02-06 | Brophy Michael Burkes CHIEF FINANCIAL OFFICER | Exercise or conversion · Stock Option (right to buy) 10b5-1 | −23,959 | 0 | ||
| 2024-02-06 | Sheena Jonathan Director | Sale 10b5-1 | −3,000 | $70.00 | $210K | 18,155 |
| 2024-02-06 | Sheena Jonathan Director | Sale 10b5-1 | −3,000 | $70.00 | $210K | 18,155 |
| 2024-02-01 | Brophy Michael Burkes CHIEF FINANCIAL OFFICER | Sale | −22,281 | $67.73 | $1.5M | 70,646 |
| 2024-01-29 | Brophy Michael Burkes CHIEF FINANCIAL OFFICER | Sale | −3,235 | $65.09 | $211K | 92,927 |
| 2024-01-29 | Sheena Jonathan Director | Sale | −546 | $65.09 | $36K | 478,585 |
| 2024-01-29 | RABINOWITZ DANIEL SEC. AND CHIEF LEGAL OFFICER | Sale | −4,265 | $65.09 | $278K | 204,218 |
Page 80 of 85 · 1,682 trades